---

Highlights for August 2016

1. Aurobindo, Intas in race for USD1 billion buyout of Teva UK, submit binding offers
2. Dr. Reddy’s completes acquisition of 8 ANDAs in the US from Teva Pharma
3. Lupin acquires 21 branded products from Shionogi in Japan
4. Catalent Biologics and Zumutor collaborate to develop antibodies with enhanced ADCC Activity
5. Piramal ties up with Bain Capital to invest in stressed assets
6. Tata Trusts, Gilead sign MoU to address viral hepatitis
7. Carlyle Group readies bid for Claris’s injectable drugs business
8. Carlyle Group has emerged as the front-runner to buy out the stakes of three PE investors in Bharat Biotech